122 results on '"Maan, R."'
Search Results
2. Multivalent interactions facilitate motor-dependent protein accumulation at growing microtubule plus-ends
3. Ribavirin steady‐state plasma level is a predictor of sustained virological response in hepatitis C–infected patients treated with direct‐acting antivirals
4. A Comparison between the Horizontal Condylar and Bennett Angles of Iraqi Full Mouth Rehabilitation Patients by Using Two Different Articulator Systems (An In-Vivo Study)
5. Serum xanthine oxidase profile in stressed Marwari sheep from arid tracts in India
6. An evaluation of the influence of different finishing lines on the fracture strength of full contour zirconia CAD/CAM and heat press all-ceramic crowns
7. Estimation of the Bennett mandibular immediate side shift in Iraqi full mouth rehabilitation patients (An in vivo study)
8. An evaluation of an Iraqi phosphate-bonded investment and a commercial type on the marginal fit of ceramometalcopings using three different investing and burnout techniques
9. Insights Into The Effect of Shelter Modification On Key Biochemical Aspects vis-a-vis the Performance of Sahiwal Zebu Cows Reared in Hot Arid Ambience
10. Osteoporosis: a Common Health Problem in Senior Adult Population of Arar City, Saudi Arabia
11. Shape and Size Control of Artificial Cells for Bottom-Up Biology
12. Adhesion of Active Cytoskeletal Vesicles
13. Osteoporosis: a Common Health Problem in Senior Adult Population of Arar City, Saudi Arabia
14. Adhesion of active cytoskeletal vesicles
15. A175 CAN HCV CORE ANTIGEN REPLACE HCV RNA TESTING IN THE ERA OF DIRECT-ACTING ANTIVIRALS?
16. Reconstitution of composite actin and keratin networks in vesicles
17. Ribavirin steady-state plasma level is a predictor of sustained virological response in hepatitis C-infected patients treated with direct-acting antivirals
18. Editorial: hepatitis C direct acting antiviral agents and the kidney—authors’ reply
19. Journal of the Society for Arts, Vol. 23, no. 1171
20. Editorial: hepatitis C direct acting antiviral agents and the kidney-authors’ reply
21. The frequency of acute kidney injury in patients with chronic hepatitis C virus infection treated with sofosbuvir-based regimens
22. Can HCV core antigen replace HCV RNA testing in the era of direct-acting antivirals?
23. Impact of genotype 3 on clinical outcome in patients with hepatitis C: both diabetes meliitus and liver disease progression
24. High Risk of Infection During Triple Therapy with First-Generation Protease Inhibitors: A Nationwide Cohort Study
25. Antiviral Therapy for Chronic HCV Infection - Tolerability and Outcome
26. Recent advances in managing chronic HCV infection: Focus on therapy in patients with severe liver disease
27. The evaluation of vertical marginal discrepancy induced by using as cast and as received base metal alloys with different mixing ratios for the construction of porcelain fused to metal copings
28. Safety of Direct-Acting Antivirals-Based Therapy for the Treatment of Patients with Chronic Hepatitis C Virus Infection and Cirrhosis: Results from an International Multicenter Cohort Study
29. Sustained Virological Response Results in Regression of Liver Stiffness in Patients with Chronic Hepatitis C Virus Infection
30. Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies
31. ITPA polymorphisms are associated with hematological side effects during antiviral therapy for chronic HCV infection
32. Real-World Medical Costs of Antiviral Therapy Among Patients With Chronic Hcv Infection and Advanced Hepatic Fibrosis
33. P0761 : Epidemiological trends among patients with chronic HCV infection in a tertiary centre in the Netherlands
34. P1286 : Low prevalence of positive viral serology for HBV and HCV among a general dutch elderly population: Results from the rotterdam study
35. Ribavirin steady-state plasma level is a predictor of sustained virological response in hepatitis C-infected patients treated with direct-acting antivirals.
36. P1176 INCIDENCE AND RISK FACTORS FOR INFECTIONS DURING INTERFERON-BASED TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH ADVANCED HEPATIC FIBROSIS
37. SAT-247 - Safety of Direct-Acting Antivirals-Based Therapy for the Treatment of Patients with Chronic Hepatitis C Virus Infection and Cirrhosis: Results from an International Multicenter Cohort Study
38. SAT-465 - Sustained Virological Response Results in Regression of Liver Stiffness in Patients with Chronic Hepatitis C Virus Infection
39. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study
40. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study.
41. CLOUD FOR SMALL BUSINESSES: SMBS CAN TAKE ADVANTAGE OF COMPETITION BETWEEN BIG GIANTS.
42. Velocity-Voidage Relationships for Fluidization and Sedimentation in Solid-Liquid Systems
43. Validation of a simple score to identify patients who can safely use protease inhibitor-based therapy for HCV infection.
44. PGI14 - Real-World Medical Costs of Antiviral Therapy Among Patients With Chronic Hcv Infection and Advanced Hepatic Fibrosis
45. Volumetric and acoustic studies of binary liquid mixtures of alkoxypropanols with ethyl acetoacetate in the temperature range (288.15-308.15) K
46. Velocity-Voidage Relationships for Fluidization and Sedimentation in Solid-Liquid Systems
47. PGI14 Real-World Medical Costs of Antiviral Therapy Among Patients With Chronic Hcv Infection and Advanced Hepatic Fibrosis
48. IN A BAGHDAD GARDEN: TO THE ZINNIAS, THE SUN IS LOVE.
49. Extensive splanchnic vein thrombosis after SARS-CoV-2 vaccination: A Vascular Liver Disease Group (VALDIG) initiative.
50. Graft Steatosis and Donor Diabetes Mellitus Additively Impact on Recipient Outcomes After Liver Transplantation-A European Registry Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.